Core Insights - The ASEBIR 2025 conference in Barcelona highlighted Spain's leadership in assisted reproductive technology, with over 200 compliant reproductive centers and more than 220,000 IVF cycles annually, accounting for over 35% of Europe's total [1] - Genea Biomedx participated with a focus on "AI reshaping the future of assisted reproduction," engaging with top European reproductive center leaders and gaining significant attention [3][4] Group 1: Conference Highlights - The AI embryology seminar led by Genea Biomedx received the highest rating at the conference, attracting over 300 reproductive medicine experts and demonstrating the effectiveness of AI in embryo selection, improving quality screening efficiency by 40% [5][12] - Genea Biomedx hosted a high-end dinner themed "Building a New Ecosystem for Reproductive Health," gathering leading embryologists and scientists, showcasing the brand's credibility in the European market [8][10] Group 2: Awards and Talent Development - The establishment of the "Reproductive Medicine Innovation Award" in collaboration with ASEBIR recognized the "Cryopreservation of Sperm Technology" project at Dexeus Mujer clinic, aligning with Genea Biomedx's non-invasive technology philosophy [10][11] - The "Genea Biomed X ASEBIR Junior Embryologist Scholarship" program was launched, providing training opportunities for emerging talent in the field, enhancing the brand's influence in global reproductive health networks [11][12] Group 3: Industry Perspective - Genea Biomedx's performance at ASEBIR 2025 reflects its technological advancements and strategic positioning, with core products like the GERI incubator and GEMS culture media receiving international certifications [12][14] - The conference underscored the growing consensus that AI technology significantly optimizes embryo culture and evaluation processes, enhancing embryo development potential and implantation success rates [12][14]
贝康医疗-B(02170.HK)：闪耀西班牙，ASEBIR 2025展现全球领导力